Skip to main content
Menu
US

GSP Neonatal IRT kit

The diagnosis of cystic fibrosis is often based on the symptoms, which may cause considerable delays in the disease intervention, and evidence indicates that early attention may be important in determining the clinical outcome.

Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.

Overview

The amount of the pancreatic enzyme, immunoreactive trypsin(ogen) (IRT) has been shown to be increased in blood of CF patients especially during the first weeks after birth.

GSP Neonatal IRT assay

The GSP Neonatal IRT assay allows the quantitative determination of IRT from dried blood spot specimens, and is intended as an aid in screening for cystic fibrosis.

  • Linear calibration curve fitting - improved precision
  • Incubation time 2 h
  • Sensitive, robust DELFIA chemistry for confidence in results
  • All reagents are ready to use
  • The kit contains reagents and plates for 1152 tests (12 plates)

Specifications

Application
Newborn Screening
Assay Technology
DELFIA
Brand
GSP®
Detection Method
DELFIA
Disorders
Cystic Fibrosis
Sample Type
Dried blood spots

Resources

SDS, COAs, Manuals and more

Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.

Safety data sheet
+ Show more
Scroll Icon